Kenan Ateş

Kenan Ateş

Auto-generated profile, based on publicly available information

Kenan Ateş

Division of Nephrology, Ankara University Faculty of Medicine, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
SOSavas Ozturk
Savas Ozturk
KTKenan Turgutalp
Kenan Turgutalp
MAMustafa Arici
Mustafa Arici
MGMahmut Gok
Mahmut Gok
MImahmud islam
mahmud islam
KAKenan Ates
Kenan Ates
Objective Older adults with comorbidities have been reported to be at higher risk for adverse outcomes of Coronavirus disease 2019(COVID-19). The characteristics of COVID-19 in older patients and its clinical outcomes in different kidney disease groups are not well known. Methods Data were retrieved from a national multicentric database supported by Turkish Society of Nephrology, which consists of retrospectively collected data between April 17, 2020, and December 31, 2020. Hospitalized patients aged 18 years or older with confirmed COVID-19 diagnosis suffering from stage 3-5 chronic kidney disease(CKD) or on maintenance hemodialysis(HD) treatment were included in the database. Non-uremic hospitalized patients with COVID-19 were also included as the control group. Results We included 879 patients [388(44.1%) female, median age: 63(IQR:50-73) years]. The percentage of older patients in the CKD group was 68.8%(n=188/273), in HD group was 49.0%(n=150/306) and in the control group was 30.4%(n=70/300). Comorbidities were higher in the CKD and HD groups. The rate of presentation with severe-critical disease was higher in the older CKD and HD groups (43.6%, 55.3%, 16.1%, respectively). Among older patients, the intensive care unit(ICU) admission rate was significantly higher in the CKD and HD group than in the control group (38.8%, 37.3%, and 15.7%, respectively). In-hospital mortality or death and/or ICU admission rates in the older group were significantly higher in the CKD (29.3% and 39.4%) and HD group (26.7% and 30.1%) compared to the control group (8.6% and 17.1%). In the multivariate analysis, in-hospital mortality rates in CKD and HD groups were higher than control group [Hazard ratio(HR): 4.33([95% confidence interval(CI): 1.53-12.26] and HR: 3.09(95%CI: 1.04-9.17), respectively]. Conclusion Among older COVID-19 patients, in-hospital mortality is significantly higher in those with stage 3-5 CKD and on maintenance HD than older patients without CKD regardless of demographic characteristics, comorbidities, clinical and laboratory data on admission.

21 October 2013 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
UİUfuk İlgen
Ufuk İlgen
ZÇZeynep Kendi Çelebi
Zeynep Kendi Çelebi
IKIsinsu Kuzu
Isinsu Kuzu
SKSim Kutlay
Sim Kutlay
GNGokhan Nergizoglu
Gokhan Nergizoglu
KAKenan Ates
Kenan Ates
Hidradenitis suppurativa (HS), also known as Verneuil's disease [ 1] or acne inversa, is characterized by hyperkeratosis of the follicular epithelium, resulting in obstruction of the follicular stoma and chronic perifollicular inflammation with remissions and relapses, usually involving skin overlying the axillary, inguinal, perianal, perineal and inframammarian regions. It usually presents in the second and third decades of life, has a female preponderance, no racial predilection and a prevalence of 4%. Some causing factors might be obesity and related hormonal changes, hyperandrogenism, immunologic and genetic status, diet and smoking [ 2]. The diagnosis is based on the presence of relapsing lesions in typical anatomical regions. HS may be localized with chronic, relapsing, superficial papulopustular lesions, as it may be associated with deep, widespread abscesses, sinus tracts, fistulas, malignancies like squamous cell carcinoma and systemic complications like arthropathy or anaemia [ 3]. Besides topical and surgical care, therapy with antibiotics, steroids, retinoids and anti-TNF agents is usually considered. Rarely, amyloidosis may complicate the cutaneous disease [ 4].

15 April 2025 in Turkish Journal of Nephrology
Verified
Journal Article
Open access
NSNurhan Seyahi
Nurhan Seyahi
IKIsmail Kocyigit
Ismail Kocyigit
NENecmi Eren
Necmi Eren
HTHalil Zeki Tonbul
Halil Zeki Tonbul
ETErhan Tatar
Erhan Tatar
KAKenan Ateş
Kenan Ateş
Background: Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis (PD), and transplan tation annually. Registry reports are printed every year as a booklet, and this is the 34th year of the registry reports. The registry is in close collaboration with international registries. Methods: In this paper, we summarized data from the 2023 registry report and provided yearly trends for managing end stage kidney disease. Results: The number of patients on kidney replacement therapy (KRT) increased; at the end of 2023, 89 527 patients were on KRT. The prevalence and incidence of end-stage kidney disease were 1048.7 and 159.8 per million population, respec tively. Diabetes was the most common cause of end-stage kidney disease. Hemodialysis (70.88%) was the most common type of treatment modality, followed by transplantation (25.01%) and PD (4.11%). Conclusion: End-stage kidney disease is a critical and growing health problem for our country. The kidney registry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem. Cite this article as: Seyahi N, Koçyi#it ", Eren N, et!al. Current Status of Kidney Replacement Therapy in Türkiye: A Summary of 2023 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2025;34(2):141-148.

7 April 2026 in Turkish Journal of Nephrology
Verified
Journal Article
Open access
PDF file
NSNurhan Seyahi
Nurhan Seyahi
IKIsmail Kocyigit
Ismail Kocyigit
MDMevlut Tamer Dincer
Mevlut Tamer Dincer
NENecmi Eren
Necmi Eren
HTHalil Zeki Tonbul
Halil Zeki Tonbul
KAKenan Ateş
Kenan Ateş
Background: The Turkish Society of Nephrology registry annually collects nationwide data on hemodialysis, peritoneal dialysis (PD), and kidney transplantation. Registry findings are published annually; the current report marks the thirty-fifth year of data collection. The registry is in close collaboration with international registries. Methods: This study summarized data from the 2024 registry report and provided yearly trends in the management of end-stage kidney disease. Results: The number of patients receiving kidney replacement therapy continued to rise, reaching 92 461 individuals by the end of 2024. The prevalence and incidence of end-stage kidney disease were 1079.3 and 164 per million population, respec tively. Diabetes mellitus remained the leading cause of end-stage kidney disease. Hemodialysis was the most common type of treatment modality (70.4%), followed by kidney transplantation (25.4%) and PD (4.2%). Conclusion: End-stage kidney disease remains a major and expanding public health challenge in Türkiye. The kidney reg istry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem. Cite this article as: Seyahi N, Koçyiğit İ, Dinçer MT, et al. Current status of kidney replacement therapy in Türkiye: A summary of 2024 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2026;35(2):163-170.

1 July 2025 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
PDF file
GKGizem Kumru
Gizem Kumru
ŞMŞeyda Şahika Mutlu
Şeyda Şahika Mutlu
EBElif Naz Başarır
Elif Naz Başarır
KAKenan Ateş
Kenan Ateş
ŞEŞehsuvar Ertürk
Şehsuvar Ertürk
KKKenan Keven
Kenan Keven
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.

30 September 2025 in Turkish Journal of Nephrology
Verified
Journal Article
Open access
GKGizem Kumru
Gizem Kumru
ŞEŞayeste Akkan Eren
Şayeste Akkan Eren
SSSule Sengul
Sule Sengul
KAKenan Ateş
Kenan Ateş
KKKenan Keven
Kenan Keven
Kidney transplantation,peritoneal dialysis,peritoneal dialysis discontinuation,peritonitis,time on peritoneal dialysis,transplant failure